Emergent BioSolutions, Inc. (EBS)
6.04
+0.13
(+2.20%)
USD |
NYSE |
Aug 31, 14:43
Emergent BioSolutions Cash from Operations (Annual) : 170.60M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 170.60M |
| December 31, 2024 | 58.70M |
| December 31, 2023 | -206.30M |
| December 31, 2022 | -34.10M |
| December 31, 2021 | 320.20M |
| December 31, 2020 | 536.00M |
| December 31, 2019 | 188.00M |
| December 31, 2018 | 41.80M |
| December 31, 2017 | 206.70M |
| December 31, 2016 | 53.49M |
| December 31, 2015 | 44.46M |
| December 31, 2014 | 112.32M |
| Date | Value |
|---|---|
| December 31, 2013 | 96.97M |
| December 31, 2012 | 39.64M |
| December 31, 2011 | 14.59M |
| December 31, 2010 | 99.54M |
| December 31, 2009 | 30.51M |
| December 31, 2008 | 7.317M |
| December 31, 2007 | 55.45M |
| December 31, 2006 | -4.061M |
| December 31, 2005 | 42.25M |
| December 31, 2004 | 9.196M |
| December 31, 2003 | 11.07M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Exelixis, Inc. | 884.27M |
| Capricor Therapeutics, Inc. | -69.81M |
| ADMA Biologics, Inc. | 50.40M |
| Akebia Therapeutics, Inc. | 67.99M |
| Arcutis Biotherapeutics, Inc. | -5.625M |